SYSTEMIC DELIVERY, LOCAL ACTIVITY

The pharmaletter

Good Therapeutics spinout Bonum banks $93 million in Series A

Media

GeekWire

Seattle biotech startup born out of a Roche buyout lands $93M to advance therapies

Media

BioPharmaDive

After $250M Roche buyout, a startup plans a second strike with fresh funding

Media

Endpoints News

The crew that sold its lead IL-2 program to Roche is back with $93M to work on more next-gen I/O drugs

Media

Fierce Biotech

Roche-backed Bonum bags $93M series A to develop new class of conditionally active therapies

Media

BioSpace

Good Therapeutics’ Offshoot Bonum Launches with $93 Million in Series A (Updated)

Media
1 2 3